Table 1.
Analyses of HMA combinations with AraC on BCP-ALL cells
| Drug combination effect | |||||||
|---|---|---|---|---|---|---|---|
| AZA + AraC | AZA + AraC (24 h) | AraC + AZA (24 h) | DEC + AraC | DEC + AraC (24 h) | AraC + DEC (24 h) | ||
| SEM | Metabolism | 0.095 | 0.045 | 0.004 | 0.022 | − 0.039 | − 0.077 |
| Proliferation | 0.064 | 0.006 | 0.001 | 0.017 | − 0.048 | 0.041 | |
| RS4;11 | Metabolism | 0.076 | − 0.055 | − 0.018 | 0.128 | − 0.032 | − 0.043 |
| Proliferation | 0.016 | 0.044 | − 0.003 | 0.000 | 0.025 | 0.076 | |
Drug combination effect: difference between the observed and the expected inhibition (E) of combined treatment. E is calculated as follows: E = (A + B) − (A*B); A is inhibition effect of drug A; B inhibition effect of drug B values > 0: synergistic, values < 0: antagonistic